Home
About
Team
Portfolio
News
FAQ
Contact

News

Berwyn biopharma firm files for IPO

Sep 10, 2019

Berwyn biopharma firm files for IPO

Comments are closed.

Current News

HueDx Transforms Point-of-Care Diagnostics with AI-Powered Smartphone Solutions
Palvella Therapeutics Awarded Up to $2.6 million Grant from the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development to Support Phase 3 Single-Arm, Baseline-Controlled Trial in Microcystic Lymphatic Malformations
Wellsheet and Wolters Kluwer Collaborate to Integrate AI-Powered Clinical Workflows with UpToDate
IVIEW Therapeutics Inc. Completes Patient Recruitment for Phase 1/2 Trial of IVW-1001 Ophthalmic Eyelid Wipe in Dry Eye Disease Patients
The pathogenic role of retinoid nuclear receptor signaling in cancer and metabolic syndromes

© 2013-2024 BioAdvance. All rights reserved.